ESMO 2018: Sarah Verhoeff - PET/CT bij mRCC - presentatie

 

Sarah Verhoeff

PET/CT bij mRCC

Sarah Verhoeff presenteert haar poster aangaande imaging van mccRCC met PET/CT met 89Zr-girentuximab.

 

Referentie

S. Verhoeff et al. Lesion detection by ceCT, 89Zr-girentuximaband FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) (888P), ESMO 2018
 

 

1218ONC1089566
×

Ask Speakers

×

Medical Information Request